Marie A. Scully

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 194 publications

von Willebrand factor cleaving protease-ADAMTS 13.

von Willebrand factor cleaving protease-ADAMTS 13.

Journal: Haematologica

Published: September 01, 2026

Pharmacodynamics of Caplacizumab in Healthy Volunteers and Phase 2/3 Trial Patients with Immune-mediated Thrombotic Thrombocytopenic Purpura.

Pharmacodynamics of Caplacizumab in Healthy Volunteers and Phase 2/3 Trial Patients with Immune-mediated Thrombotic Thrombocytopenic Purpura.

Journal: Thrombosis and haemostasis

Published: July 15, 2026

Refractoriness in TTP: challenges and solutions.

Refractoriness in TTP: challenges and solutions.

Journal: Blood

Published: May 21, 2026

Natural History and Treatment Outcomes of Congenital Thrombotic Thrombocytopenic Purpura: A Retrospective Longitudinal Cohort Study.

Natural History and Treatment Outcomes of Congenital Thrombotic Thrombocytopenic Purpura: A Retrospective Longitudinal Cohort Study.

Journal: Journal of health economics and outcomes research

Published: April 16, 2026

Recurrent thrombocytopenia in immune thrombotic thrombocytopenic purpura during the caplacizumab era.

Recurrent thrombocytopenia in immune thrombotic thrombocytopenic purpura during the caplacizumab era.

Journal: British journal of haematology

Published: March 25, 2026

Emerging from the shadows of congenital TTP.

Emerging from the shadows of congenital TTP.

Journal: Blood advances

Published: March 10, 2026

Delayed ADAMTS13 normalisation in caplacizumab/PEX treated patients associated with anti-ADAMTS13 IgG antibody boosting.

Delayed ADAMTS13 normalisation in caplacizumab/PEX treated patients associated with anti-ADAMTS13 IgG antibody boosting.

Journal: Blood advances

Published: January 09, 2026

Delayed ADAMTS13 normalization in caplacizumab/PEX-treated patients associated with anti-ADAMTS13 IgG antibody boosting.

Delayed ADAMTS13 normalization in caplacizumab/PEX-treated patients associated with anti-ADAMTS13 IgG antibody boosting.

Journal: Blood advances

Published: January 09, 2026

Modern management of congenital thrombotic thrombocytopenic purpura (cTTP).

Modern management of congenital thrombotic thrombocytopenic purpura (cTTP).

Journal: Hematology. American Society of Hematology. Education Program

Published: December 05, 2025

Thrombotic thrombocytopenic purpura: celebrating 25 years of ADAMTS13.

Thrombotic thrombocytopenic purpura: celebrating 25 years of ADAMTS13.

Journal: Blood

Published: November 04, 2025

Thrombotic thrombocytopenic purpura: celebrating 25 years of ADAMTS13.

Thrombotic thrombocytopenic purpura: celebrating 25 years of ADAMTS13.

Journal: Blood

Published: November 04, 2025

Genetics of thrombotic thrombocytopenic purpura: systematic review in immune and congenital thrombotic thrombocytopenic purpura.

Genetics of thrombotic thrombocytopenic purpura: systematic review in immune and congenital thrombotic thrombocytopenic purpura.

Journal: Journal of thrombosis and haemostasis : JTH

Published: October 27, 2025

Showing 1-12 of 194

Last Updated: 09/26/2026